KCNN4 and cancer: The pharmacological activation of KCa3.1 using positive modulators has been proposed as a novel way to boost the suppressed immune system in its fight against cancer (Chandy and Norton, 2016; Brown et al., 2017) [reviewed recently in (Chirra et al., 2022)].